A virtual reality application to reduce delirium in ICU patients.
Virtual PARTNER (Provide, Activate, Restore, Track, iNspire, Educate, Rehabilitate): Multi-component virtual reality application to target a reduction in delirium in the intensive care unit.
['FUNDING_SBIR_1'] · RALPHVR INC. · NIH-11007082
This study is testing a virtual reality program that helps ICU patients stay mentally active, sleep better, and move around more, all to prevent confusion and improve their recovery, while making it easier for nurses to provide care.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RALPHVR INC. (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11007082 on ClinicalTrials.gov |
What this research studies
This research investigates a multi-component virtual reality application designed to help reduce the incidence of delirium in patients within the intensive care unit (ICU). By utilizing technology, the application aims to provide cognitive stimulation, optimize sleep, and encourage patient mobilization, all of which are crucial in preventing delirium. The approach focuses on delivering these interventions in a way that minimizes the burden on nursing staff, ensuring that care remains effective and efficient. Patients will engage with the virtual reality system as part of their care routine, potentially improving their cognitive outcomes and overall recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients admitted to the ICU who are at high risk for developing delirium.
Not a fit: Patients who are not admitted to the ICU or those who do not exhibit risk factors for delirium may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the rates of delirium in ICU patients, leading to better recovery outcomes and improved quality of life post-discharge.
How similar studies have performed: Previous research has shown that non-pharmacological interventions can effectively reduce delirium in hospitalized patients, suggesting that this technology-based approach may also be successful.
Where this research is happening
LEXINGTON, UNITED STATES
- RALPHVR INC. — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOAGLAND, RICHARD — RALPHVR INC.
- Study coordinator: HOAGLAND, RICHARD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.